ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00057473
Recruitment Status : Completed
First Posted : April 3, 2003
Last Update Posted : April 14, 2011
Sponsor:
Information provided by:
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2004
  Actual Study Completion Date : February 2004
  Certification/Extension First Submitted : February 3, 2010